Company / Current Assets
Syndax Pharmaceuticals Inc Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$528.1M
FY2025
5-year range
$448.4M / $603.1M
FY2021-FY2025
Trend
-12.4%
vs FY2024
Sector context
#111 of 213
Health Care
What the data says
At $528M, Syndax Pharmaceuticals Inc's current assets ranks #111 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $62M in FY2019 to $603M in FY2024.
Based on SEC 10-K filings.
$528M in FY2025 with a 5-year CAGR of +12.1%.
Declined from $581M to $528M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +2.5%
- 5-Year CAGR
- +12.1%
- 10-Year CAGR
- -
Sector benchmark
#111 of 213 in Health CareTop 52% of 213This company $528.1M Sector average $2.5B
▼
-79.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.1%, indicating consistent growth.
- In FY2025, current assets decreased 12.4% year-over-year.
- Ranks #111 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $528.1M | -12.4% |
| FY2024 | $603.1M | +3.8% |
| FY2023 | $580.9M | +18.6% |
| FY2022 | $489.8M | +9.2% |
| FY2021 | $448.4M | +50.0% |
| FY2020 | $298.9M | +379.5% |
| FY2019 | $62.3M | -25.2% |
| FY2018 | $83.3M | -37.5% |
| FY2017 | $133.4M | +23.0% |
| FY2016 | $108.5M | +23.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026